Differentiation of Acquired Immune Deficiency Syndrome Related Primary Central Nervous System Lymphoma from Cerebral toxoplasmosis with Use of Susceptibility-Weighted Imaging and Contrast Enhanced 3D-T1WI
•SWI and CE 3D-T1WI were useful in AR-PCNSL and cerebral toxoplasmosis.•AR-PCNSL showed a higher SWI-ILSS and larger 3D-T1WI volume enhancement.•AR-PCNSL was more likely to present incomplete, irregular LSIRs and CLSI on SWI.•Cerebral toxoplasmosis was more likely to present smooth LSIRs on SWI. We...
Gespeichert in:
Veröffentlicht in: | International journal of infectious diseases 2021-12, Vol.113, p.251-258 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •SWI and CE 3D-T1WI were useful in AR-PCNSL and cerebral toxoplasmosis.•AR-PCNSL showed a higher SWI-ILSS and larger 3D-T1WI volume enhancement.•AR-PCNSL was more likely to present incomplete, irregular LSIRs and CLSI on SWI.•Cerebral toxoplasmosis was more likely to present smooth LSIRs on SWI.
We aimed to investigate whether susceptibility-weighted imaging (SWI) and contrast-enhanced 3D-T1WI can differentiate Acquired Immune Deficiency Syndrome-Related Primary Central Nervous System Lymphoma (AR-PCNSL) from cerebral toxoplasmosis.
This was a prospective cohort study. 20 AIDS patients were divided into AR-PCNSL group (13 cases) and cerebral toxoplasmosis group (7 cases) based on pathology results. We analyzed the appearance of lesions on SWI and enhanced 3D T1WI and ROC curves in the diagnosis of AR-PCNSL and cerebral toxoplasmosis.
Cerebral toxoplasmosis was more likely to show annular enhancement (p = 0.002) and complete smooth ring enhancement (p = 0.002). It was also more likely to present a complete, smooth low signal intensity rim (LSIR) (p = 0.002) and an incomplete, smooth LSIR (p = 0.019) on SWI. AR-PCNSL was more likely to present an incomplete, irregular LSIR (p |
---|---|
ISSN: | 1201-9712 1878-3511 |
DOI: | 10.1016/j.ijid.2021.10.023 |